EyePoint Pharmaceuticals, Inc.EYPTNASDAQ
LOADING
|||
| Metric | Dec 20 | Dec 21 | Dec 22 | Dec 23 | Dec 24 |
|---|---|---|---|---|---|
| Revenue | 34 | 37↑7.3% | 41↑12.1% | 46↑11.1% | 43↓6.0% |
| Gross Profit | 29 | 29↑0.5% | 33↑15.0% | 41↑25.1% | 40↓4.4% |
| Operating Income | -37 | -55↓48.2% | -100↓80.3% | -75↑24.7% | -146↓94.3% |
| Net Income | -45 | -58↓28.7% | -102↓75.0% | -71↑30.8% | -131↓84.9% |
| EBITDA | -35 | -50↓41.3% | -97↓92.7% | -69↑28.6% | -129↓87.3% |
| EPS Diluted | -3.54 | -2.03↑42.7% | -2.74↓35.0% | -1.82↑33.6% | -2.32↓27.5% |